NFKB1 and Alzheimer disease: Induction of pro-inflammatory genes mediated via the NFκB-RE has been shown to trigger neuroinflammation and deposition of Aβ [48], and at least 11 anti-AD drugs are capable of inhibiting the NFκB signaling pathway [49].